Sharon Correia | Executive Vice President & Chief Strategy Officer

Sharon has more than 20 years of life science marketing and corporate communications management experience at both public and private companies. Throughout her career, Sharon has worked on integrated corporate communications strategies for investor, media and professional advocacy relations; and she has led the communications process for multiple NDA approvals, product launches, as well as several sNDAs and IPOs.

Previous Experience
Prior to joining LHS, Sharon was Senior Director of Corporate Communications at Navidea Biopharmaceuticals, a biotech focused on development and commercialization of immunodiagnostics and therapeutics to identify and treat diseases where she launched their first immuno-oncology product. Sharon was a key strategic partner in developing and managing external and internal communications to effectively influence key investor, stakeholder, medical and media perception of Navidea and drive engagement.

Previously, Sharon held communication management roles with BioScale, Inc. (now Proterix Bio), Alseres Pharmaceuticals, Aderis Pharmaceuticals, Oscient, Caliper Life Sciences and Millipore.


Digital/Social media strategy
Government affairs
Integrated corporate marketing & communications strategies
Internal/external communications planning
Investor, public and professional advocacy relations
KOL/Patient/Influencer communications
Strategic planning
Technical & scientific communications
Tradeshow, conference & event planning
Website. Branding, and corporate collateral development


Bachelor of Science in Biochemistry, Minor in Chemistry, Pennsylvania State University

Graduate courses in Management and Finance, American University and NVCC


Skiing, painting, singing, decorating and sports


National Investor Relations Institute, New England Women in Science Executives, Public Relations Society of America, Mass Bio Communications Group

Phone: (617) 412-8779